Publications

  • HOME
  • Publications
  • 24. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway 

    Jung, K. H.; Choi, M.-J.; Hong, S.; Lee, H.; Hong, S.-W.; Zheng, H.-M.; Lee, H. S.; Hong, S.*; Hong, S.-S.*

    Cancer Lett. 2012, 316, 187-195.

  • 23. Structure-Based De Novo Design and Biochemical Evaluation of Novel BRAF Kinase Inhibitors 

    Park, H.; Jeong, Y.; Hong, S.

    Bioorg. Med. Chem. Lett. 201222. 1027. 

  • 22. Nocodazole is a High-Affinity Ligand for the Cancer-Related Kinases ABL, c-KIT, BRAF, and MEK 

    Park, H.; Hong, S.; Hong, S.

    ChemMedChem. 20127, 53-56.

  • 21. A Novel Imidazopyridine Analogue as a Phosphatidylinositol 3-Kinase Inhibitor against Human Breast Cancer 

    Lee, H.; Li, G.-Y.; Jeong, Y.; Jung, K. H.; Lee, J.-H.; Ham, K.; Hong, S.*; Hong, S.-S.*

    Cancer Lett. 2012318, 68.

  • 20. Identification of Novel Inhibitors of Tropomyosin-Related Kinase A through the Structure-Based Virtual Screening with Homology-Modeled Protein Structure 

    Park, H.; Chi, O.; Kim, J.;  Hong, S.

    J. Chem. Inform. Mod. 2011, 51, 2986-2993.

  • 19. Discovery of New Aminopyrimidine-based Phosphoinositide 3-kinase beta (PI3Kb) Inhibitors with Selectivity over PI3Ka 

    Kim, J.; Hong, S.; Hong, S.

    Bioorg. Med. Chem. Lett. 201121, 6977.

  • 18. Palladium(II)-Catalyzed Direct Intermolecular Alkenylation of Chromones 

    Kim, D.; Hong, S.

    Org. Lett. 201113, 4466-4469.

  • 17. Identification of Novel BRAF Kinase Inhibitors with Structure-Based Virtual Screening  

    Park, H.; Choi, H.; Hong, S.; Hong, S.

    Bioorg. Med. Chem. Lett. 201121, 5753.  

  • 16. Synergistic Effect of Graphene Oxide/MWCNT Films in Laser Desorption/Ionization Mass Spectrometry of Small Molecules and Tissue Imaging 

    Kim, Y.-K.; Na, H.-K.; Kwack, S.-J.; Ryoo, S.-R.; Lee, Y.; Hong, S.; Hong, S.; Jeong, Y.; Min, D.-H.

    ACS. Nano2011, 5, 4550-4561.

  • 15. Overcoming Metastatic Melanoma with BRAF Inhibitors 

    Hong, S.; Hong, S.

    Arch. Pharm. Res. 2011, 34, 699-701.